Community-acquired pneumonia: New guidelines for management

Current Opinion in Infectious Diseases

Volumn 14, Issue 2, 2001, Pages 161-164

  File T M , Jr ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; TETRACYCLINE DERIVATIVE;

ANTIMICROBIAL THERAPY; BACTERIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; HOSPITAL PATIENT; HUMAN; LEGIONELLA; MYCOPLASMA PNEUMONIAE; OUTPATIENT; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0035077141     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200104000-00009     Document Type: Review

References (9)

1. Management of adult community-acquired lower respiratory tract infections
2. Management of community-acquired pneumonia in the era of pneumococcal resistance
3. Practice guidelines for the management of community-acquired pneumonia in adults
4. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
5. Bacteremic pneumonia due to multi-drug resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin
6. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin
7. Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia
8. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: A survey of nonteaching US community hospitals